Eli Lilly 2025 Outlook Raised as Mounjaro, Zepbound Sales Soar

Eli Lilly 2025 Outlook Raised as Mounjaro, Zepbound Sales Soar

Eli Lilly & Co (NYSE:LLY) has done it again, posting another quarter of top of the line results as the company increases its 2025 guidance on blockbuster sales from Mounjaro and Zepbound, the firm’s top two drug discoveries to date for the treatment of diabetes and weight loss. The pharmaceutical behemoth crushed second-quarter views as … Read more

Samsung Galaxy S25 Edge: Expected Price, Launch & Features

Samsung Galaxy S25 Edge: Expected Price, Launch & Features

Global Launch Timeline: Expected to be released in April 2025 following its showcase at MWC 2025; noted on BIS India for a launch that is imminent. Premium Pricing: Priced between €1,200 and €1,400 in Europe (approximately ₹1.13 lakh to ₹1.32 lakh), and $999 (around ₹87,150) in the US for the model featuring 12GB RAM with … Read more